MicroRNA-125b Induces Metastasis by Targeting STARD13 in MCF-7 and MDA-MB-231 Breast Cancer Cells

MicroRNAs (miRNAs) are a class of small noncoding RNAs that regulate gene expression by targeting mRNAs to trigger either translation repression or mRNA degradation. miR-125b is down-regulated in human breast cancer cells compared with the normal ones except highly metastatic tumor cells MDA-MB-231. However, few functional studies were designed to investigate metastatic potential of miR-125b. In this study, the effects of miR-125b on metastasis in human breast cancer cells were studied, and the targets of miR-125b were also explored. Transwell migration assay, cell wound healing assay, adhesion assay and nude mice model of metastasis were utilized to investigate the effects of miR-125b on metastasis potential in vitro and in vivo. In addition, it was implied STARD13 (DLC2) was a direct target of miR-125b by Target-Scan analysis, luciferase reporter assay and western blot. Furthermore, activation of STARD13 was identified responsible for metastasis induced by miR-125b through a siRNA targeting STARD13. qRT-PCR, immunofluorescent assay and western blot was used to observe the variation of Vimentin and α-SMA in breast cancer cells. In summary, our study provided new insights into the function of miR-125b during the metastasis of breat cancer cells and also suggested the role of miR-125b in pro-metastasis by targeting STARD13.

[1]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[2]  Xu Ma,et al.  MiR-125b Expression Affects the Proliferation and Apoptosis of Human Glioma Cells by Targeting Bmf , 2009, Cellular Physiology and Biochemistry.

[3]  Jin-Wu Nam,et al.  Genomics of microRNA. , 2006, Trends in genetics : TIG.

[4]  I. Ng,et al.  Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Erik W Thompson,et al.  Epithelial to mesenchymal transition and breast cancer , 2009, Breast Cancer Research.

[6]  J. Lieberman,et al.  miR-200 Enhances Mouse Breast Cancer Cell Colonization to Form Distant Metastases , 2009, PloS one.

[7]  R. Worthylake,et al.  RhoA can lead the way in tumor cell invasion and metastasis. , 2011, Frontiers in bioscience.

[8]  Lijun Xu,et al.  Protein Kinase Cι Promotes Nicotine-induced Migration and Invasion of Cancer Cells via Phosphorylation of μ- and m-Calpains* , 2006, Journal of Biological Chemistry.

[9]  Yeunjoo E. Song,et al.  Defining genetic determinants of the Metabolic Syndrome in the Framingham Heart Study using association and structural equation modeling methods , 2009, BMC proceedings.

[10]  V. Ambros.  The functions of animal microRNAs , 2004, Nature.

[11]  Shinya Watanabe,et al.  NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells. , 2008, Cancer research.

[12]  D. Powe,et al.  Luminal and basal-like breast cancer cells show increased migration induced by hypoxia, mediated by an autocrine mechanism , 2011, BMC Cancer.

[13]  Jianguo Song.  EMT or apoptosis: a decision for TGF-beta. , 2007, Cell research.

[14]  Ross Tubo,et al.  Mesenchymal stem cells within tumour stroma promote breast cancer metastasis , 2007, Nature.

[15]  C. Benz,et al.  Coordinate Suppression of ERBB2 and ERBB3 by Enforced Expression of Micro-RNA miR-125a or miR-125b* , 2007, Journal of Biological Chemistry.

[16]  Sendurai A Mani,et al.  Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression , 2011, Breast Cancer Research.

[17]  Yan Zhang,et al.  Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth , 2011, Breast Cancer Research.

[18]  S. Nagao,et al.  Epithelial-to-mesenchymal transition in cyst lining epithelial cells in an orthologous PCK rat model of autosomal-recessive polycystic kidney disease. , 2011, American journal of physiology. Renal physiology.

[19]  Michael F. Clarke,et al.  Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells , 2009, Cell.

[20]  Andrea Ventura,et al.  MicroRNAs and Cancer: Short RNAs Go a Long Way , 2009, Cell.

[21]  C. Croce,et al.  MicroRNAs in Cancer. , 2009, Annual review of medicine.

[22]  Gene W. Yeo,et al.  Genome‐wide approaches in the study of microRNA biology , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.

[23]  Lijun Xu,et al.  Protein kinase Ciota promotes nicotine-induced migration and invasion of cancer cells via phosphorylation of micro- and m-calpains. , 2006, The Journal of biological chemistry.

[24]  Giovanni Vanni Frajese,et al.  miR-221 and miR-222 Expression Affects the Proliferation Potential of Human Prostate Carcinoma Cell Lines by Targeting p27Kip1* , 2007, Journal of Biological Chemistry.

[25]  D. Srivastava,et al.  MicroRNA regulation of cardiovascular development. , 2009, Circulation research.

[26]  A. Paradiso,et al.  The Na+–H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells , 2004, Breast Cancer Research.

[27]  Yanjie Lu,et al.  MicroRNAs and apoptosis: implications in the molecular therapy of human disease , 2009, Clinical and experimental pharmacology & physiology.

[28]  C. Croce,et al.  MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. , 2007, JAMA.

[29]  C. Cooper,et al.  Rho GTPases in PC-3 prostate cancer cell morphology, invasion and tumor cell diapedesis , 2008, Clinical & Experimental Metastasis.

[30]  Q. Pan,et al.  MicroRNA‐125b suppresses the development of bladder cancer by targeting E2F3 , 2011, International journal of cancer.

[31]  C. Croce,et al.  miRNAs, Cancer, and Stem Cell Division , 2005, Cell.

[32]  S. Virtanen,et al.  Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. , 2002, Cancer research.

[33]  V. Ambros,et al.  Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation , 2004, Genome Biology.

[34]  Wenlin Huang,et al.  miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. , 2011, Cancer research.

[35]  E. Sontheimer,et al.  Origins and Mechanisms of miRNAs and siRNAs , 2009, Cell.

[36]  Ulrich Lehmann,et al.  MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes , 2011, Breast Cancer Research and Treatment.

[37]  Christopher P Evans,et al.  An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells , 2007, Proceedings of the National Academy of Sciences.

[38]  P. Brousset,et al.  Myeloid Cell Differentiation Arrest by Mir-125b-1 in Myelodysplasic Syndrome and Acute Myeloid Leukemia with the T(2;11)(p21;q23) Translocation , 2008 .

[39]  I. Ng,et al.  Deleted in liver cancer 2 suppresses cell growth via the regulation of the Raf‐1–ERK1/2–p70S6K signalling pathway , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[40]  G. M. Nagaraja,et al.  Chromosome 13q12 encoded Rho GTPase activating protein suppresses growth of breast carcinoma cells, and yeast two-hybrid screen shows its interaction with several proteins. , 2004, Biochemical and biophysical research communications.

[41]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[42]  E. Sahai,et al.  RHO–GTPases and cancer , 2002, Nature Reviews Cancer.

[43]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[44]  D. Nie,et al.  Role of Rho GTPases in breast cancer. , 2008, Frontiers in bioscience : a journal and virtual library.

[45]  Debra L Winkeljohn.  Triple-negative breast cancer. , 2008, Clinical journal of oncology nursing.

[46]  I. Ng,et al.  Deleted in Liver Cancer (DLC) 2 Encodes a RhoGAP Protein with Growth Suppressor Function and Is Underexpressed in Hepatocellular Carcinoma* , 2003, The Journal of Biological Chemistry.

[47]  Wei Xiong,et al.  MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression* , 2010, The Journal of Biological Chemistry.

[48]  S. Chu,et al.  Silibinin Inhibits Invasion of Oral Cancer Cells by Suppressing the MAPK Pathway , 2006, Journal of dental research.

[49]  Zhiyu Qian,et al.  Folate-Polyethylene Glycol Conjugated Near-Infrared Fluorescence Probe with High Targeting Affinity and Sensitivity for In Vivo Early Tumor Diagnosis , 2010, Molecular Imaging and Biology.

[50]  Kailai Sun,et al.  MiR‐125b targets BCL3 and suppresses ovarian cancer proliferation , 2011, International journal of cancer.

[51]  D. Kufe,et al.  MUCIN 1 ONCOPROTEIN EXPRESSION IS SUPPRESSED BY THE miR-125b ONCOMIR. , 2010, Genes & cancer.